Search Results
Search results for "James Hassard"
Results found for "James Hassard"
- Terry Kenakin: Allostery, Bias, and the Assays That Changed What We Could See | Dr. GPCR Ecosystem
Terry Kenakin's career tracks what happened when that picture came apart. He also describes flying back to London to show James Black the lab he had built, and being asked a single be quantified so that the numbers travel between systems rather than describing only the cells they came Kenakin frames probe dependence as the mechanism and biased signaling as the name pharmacology later than expected - 24:55 Chemokine redundancy, CCR7, and why GLP1 is the favorite - 30:10 Dinner with James
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
University School of Medicine in 1975 and then returned to join Dukeâs faculty, where he remained as a James
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
University School of Medicine in 1975 and then returned to join Dukeâs faculty, where he remained as a James
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
University School of Medicine in 1975 and then returned to join Dukeâs faculty, where he remained as a James
- Dr. Bruno Giros | Dr. GPCR Ecosystem
the Heinz Lehmann Award from the Canadian College of NeuroPsychopharmacology and the distinguished James
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Sloskyâs work has been recognized through several travel and research awards, including the William James
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
The same system yielded the discovery of beta-adrenergic receptor kinase (now GRK2) and the beta-arrestins Lefkowitz is James B. Bob is James B.
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
through multiple intracellular pathways, and ligands do not necessarily engage those pathways to the same University of Alberta and completed postdoctoral work at University College London in the laboratory of Sir James
- Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem
The same approach distinguishes what an allosteric modulator does to affinity versus efficacy, including Two assays with different sensitivities can report different behavior for the same molecule. University of Alberta and completed postdoctoral work at University College London in the laboratory of Sir James
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
Sloskyâs work has been recognized through several travel and research awards, including the William James
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Pharmacologists and Toxicologists; the British Pharmacological Societyâs Gaddum Memorial Award; the IUPHAR Sir James Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in âPharmacology & Toxicologyâ, and in 2021 also named him a Highly Cited Researcher in the additional category of âBiology
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Pharmacologists and Toxicologists; the British Pharmacological Societyâs Gaddum Memorial Award; the IUPHAR Sir James Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in âPharmacology & Toxicologyâ, and in 2021 also named him a Highly Cited Researcher in the additional category of âBiology
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Pharmacologists and Toxicologists; the British Pharmacological Societyâs Gaddum Memorial Award; the IUPHAR Sir James Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in âPharmacology & Toxicologyâ, and in 2021 also named him a Highly Cited Researcher in the additional category of âBiology
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
His team treats opioid signaling as a problem of circuit organization: the same kinases and second messengers He came to this field because a signaling cascade felt like a puzzle he could not stop thinking about Streicher's recurring example: the same molecule promotes opioid antinociception in one context, drives In the spinal cord, the same chaperone acts as a brake on ERK activation. Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
was never whether to stay open â it was how to stay open safely, and how to absorb the stress that came reflects that the most significant advances in his career didn't come from confirming a premise â they came The breakthrough came from getting deeper into why." About this episode Dr. J.
- Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays That Reflect Real Biology | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays About the Guests Jane Lamerdin is VP of R&D at Eurofins DiscoverX, where she oversees development of The guests frame their work as talking to peers who understand the same pains, not selling a catalog.
- GĂĄspĂĄr PĂĄndy-Szekeres | Dr. GPCR Ecosystem
In my free time I like to play the guitar, sing and play board games. " GĂĄspĂĄr PĂĄndy-Szekeres on the
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
In my free time I like to play the guitar, sing and play board games. " Dr.
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first came
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
headache, while preclinical evidence points to delta opioid receptor agonism as a candidate to relieve the same Scientific Themes of the Conversation The mu/delta asymmetry in migraine â why two receptors in the same Delta opioid agonists appear to relieve the same symptoms â pain, negative affect, and aura-related signs They're not in the same state as they were if they were naĂŻve. Her career path-defining moment came from a third postdoctoral experience with Dr.
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Gutkind's most cited papers came from results that directly contradicted the textbook: βγ subunits (not The 2020 Cell paper on G protein coupling specificity came from a Gordon Conference hallway conversation
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
What came next was a series of papers reframing severe COVID-19 as a disease of signaling imbalance: Not casual, not opinion-writing; dry-lab pharmacology done with the same seriousness as bench work, just A figure can travel further than the paper it came from.
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
GPCR drug discovery, the GABA-B heterodimer, the acetate that rewrote a receptor family, and why the same names keep filling GPCR conference agendas. << Back to podcast list Strategic Partner(s) Fiona Marshall Thirty Years, and the Same Names Keep the Mic One of Dr. "Having worked in GPCRs for 30 years and I look at the conferences, the same people are speaking now One of her career path-defining moments came when she visited Dr. Chris Tate and Dr.
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
outputs when expressed in HEK293 cells versus vascular smooth muscle cells, even when challenged with the same The pattern is consistent: the most important findings came from results that initially looked like mistakes Terry Hebert "The things that they originally came into place for get sampled for many other functions
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
The answer came from an unexpected source: a paper on thermostabilization of an unrelated membrane protein It came from Tate's habit of spending Friday afternoons in the library reading outside his immediate
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
Anonymous This came at just the most perfect time.
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
My name is Anita. Iâm currently a senior scientist at a biotech in Toronto, Canada. When it came time to choose my major for undergrad, I wanted something that combined both biology and But when I came across bioinformatics, I thought, âThis is it.â It combined both things I liked. Another moment came during my postdoc while working on the ligand bias project.
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
The same compound may produce a functionally meaningful shift in one cell type and a negligible one in the receptor conformation in that membrane environment, and what other proteins are competing for the same The question that followed was immediate: why hadn't anyone done the same with G-protein C-termini? Gilchrist now teaches - follow the unexpected result, ask why it happened, do not repeat it away - came The years of research that followed came directly from not dismissing it.
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
Network or Miss Out One powerful shift came when Sokhom leaned into networkingâdespite being an introvert âWhat fascinates me is how the same molecule behaves differently depending on one amino acid.â




























